News24.com: If you suffer from epilepsy and need a phone prescription, don’t feel too bad, a new study says.
The National Health and Medical Research Council found that more than 50% of doctors in the UK told patients not to take drugs for epileptic seizures when they had them.
It says this may be because many of the drugs being prescribed to treat seizures in the developing world are not approved for use in the developed world.
Read more about the study here.
The findings come as a new report from the Cochrane Collaboration, an independent international medical organisation, has warned that the US Food and Drug Administration is being too cautious in its approval of a new drug for treating epilepsy, called Zoloft.
The report, published in The Lancet Neurology, said Zolof can help treat people with epilepsy and could be used to treat the severe form of the disorder known as Lennox-Gastaut syndrome, but it has not been approved for clinical use in adults.
The Cochrane team says Zolo might help some people with severe epilepsy, but there is no evidence it works as well for the majority of people with this condition.
It says the drug has a “high” risk of causing side effects including loss of consciousness, psychosis and psychosis-like symptoms.
The drug, which has been approved by the US FDA for the treatment of severe epilepsy in adults, was approved in Britain for children, and was later withdrawn from sale in the US.
But the report said this was because it was not clear whether the drug is safe for children.
Dr Laura Brown, a neurologist at the University of Sussex, said: “I think the FDA has been a bit too cautious with Zoloploft.
I think they should be a little more careful with it.”
Zoloft can be really helpful in people with moderate or severe epilepsy and the FDA should look at that, but they’ve also said it is not recommended for adults.
“It’s probably too early to tell what’s going to happen with Zomad, so I would hope the FDA would look at Zomadic and say ‘we’re not recommending it’.”
But I do think the agency needs to do more to be a bit more cautious.
There are a few side effects, including weight gain and weight loss, and there are some complications of the medication.””
It doesn’t do much to the symptoms, but Zomapol has been shown to reduce seizures in some people,” she said.
“There are a few side effects, including weight gain and weight loss, and there are some complications of the medication.”
The study found that nearly 50% doctors in Britain told patients in their 20s and 30s not to use Zomadiocap or Zolodocap.
More than 60% of patients who were told to avoid Zomodoc were prescribed the drug by their doctors.
“What we know from the literature is that most people in the population that are prescribed Zomdiocap and Zolocap get some side effects,” Dr Brown said.
“But it’s not clear why they get any of them.”
I think we know that the drug does work and it’s a really good treatment for severe epilepsy.
But there is a lot of evidence that Zomacap doesn’t work as well in people.
“And I think that is why it’s important for the FDA to do a little bit more research into Zomavacap before it’s approved in adults.”
Dr Smith, who is also from the University Of Sussex, added: “In some cases the drug might work, in other cases it doesn’t.”
Dr Jana Koster, a GP at University College London, said there was a need for more research to help doctors understand the safety of Zomovacap.
“The real danger is the side effects that people may get.
So we need to do some really detailed and rigorous trials to see if Zomomavicap is safe,” she told News24 at the time.
Zomovacs drugs are approved in the United States and the UK for treatment of children, adolescents and adults.
They are prescribed for severe or life-threatening epilepsy in children and adults, or in children with certain other serious diseases.
Zomavacs have been approved in Europe, but only for severe seizures in adults or in people over the age of 65.
Zolovac is approved for the control of moderate to severe epilepsy (for people aged 16 to 65) in adults and for treatment for people over 65 with a chronic or life threatening disease, such as Alzheimer’s disease.
Zovac has not yet been approved as a treatment for epilepsy in people under the age in the USA.